一般外科

1. Cheng SP, Lee JJ, Chien MN, Kuo CY, Jhuang JY, Liu CL. Lymphovascular invasion of papillary thyroid carcinoma revisited in the era of active surveillance. European Journal of Surgical Oncology (Online ahead of print) doi: 10.1016/j.ejso.2020.06.044. 2. Cheng SP, Lee JJ, Chang YC, Lin CH, Li YS, Liu CL. Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer. Journal of Pathology (Online ahead of print) doi: 10.1002/path.5503. 3. Liu CL, Hsu YC, Lee JJ, Chen MJ, Lin CH, Huang SY, Cheng SP. Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells. Molecular and Cellular Endocrinology 2020;499:110595. doi: 10.1016/j.mce.2019.110595. 4. Tsai CC, Chien MN, Chang YC, Lee JJ, Dai SH, Cheng SP. Overexpression of histone H3 lysine 27 trimethylation is associated with aggressiveness and dedifferentiation of thyroid cancer. Endocrine Pathology 2019;30:305-311. doi: 10.1007/s12022-019-09586-1. 5. Hsu YC, Lee JJ, Chien MN, Chen MJ, Leung CH, Cheng SP. Is papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis. Journal of Surgical Oncology 2019;120:1023-1030. doi: 10.1002/jso.25670. 6. Chien MN, Yang PS, Hsu YC, Liu TP, Lee JJ, Cheng SP. Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation. Head & Neck 2018;40:2528-2537. doi: 10.1002/hed.25385. 7. Cheng SP, Chien MN, Wang TY, Lee JJ, Lee CC, Liu CL. Reconsideration of tumor size threshold for total thyroidectomy in differentiated thyroid cancer. Surgery 2018;164:504-510. doi: 10.1016/j.surg.2018.04.019. 8. Lee JJ, Wang TY, Liu CL, Chien MN, Chen MJ, Hsu YC, Leung CH, Cheng SP. Dipeptidyl peptidase IV as a prognostic marker and therapeutic target in papillary thyroid carcinoma. Journal of Clinical Endocrinology & Metabolism 2017;102:2930-2940. doi: 10.1210/jc.2017-00346. 9. Chien MN, Yang PS, Lee JJ, Wang TY, Hsu YC, Cheng SP. Recurrence-associated genes in papillary thyroid cancer: An analysis of data from The Cancer Genome Atlas. Surgery 2017;161:1642-1650. doi: 10.1016/j.surg.2016.12.039. 10. Cheng SP, Yang PS, Chien MN, Chen MJ, Lee JJ, Liu CL. Aberrant expression of tumor-associated carbohydrate antigen Globo H in thyroid carcinoma. Journal of Surgical Oncology 2016;114:853-858. doi: 10.1002/jso.24479. 11. Cheng SP, Liu CL, Chen MJ, Chien MN, Leung CH, Lin CH, Hsu YC, Lee JJ*. CD74 expression and its therapeutic potential in thyroid carcinoma. Endocrine-Related Cancer 2015;22:179-190. doi: 10.1530/ERC-14-0269. 12. Wang TY, Liu CL, Chen MJ, Lee JJ, Pun PC, Cheng SP. Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAF(V600E) expression in thyroid cancer. Histopathology 2015;66:447-456. doi: 10.1111/his.12562. 13. Cheng SP, Hsu YC, Liu CL, Liu TP, Chien MN, Wang TY, Lee JJ. Significance of allelic percentage of BRAF c.1799T > A (V600E) mutation in papillary thyroid carcinoma. Annals of Surgical Oncology 2014;21 Suppl 4:S619-626. doi: 10.1245/s10434-014-3723-5. 14. Cheng SP, Lee JJ, Liu TP, Yang TL, Chen HH, Wu CJ, Liu CL. Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism. Surgery 2014;155:320-328. doi: 10.1016/j.surg.2013.08.013. 15. Cheng SP, Lee JJ, Liu TP, Lee KS, Liu CL. Preoperative ultrasonography assessment of vocal cord movement during thyroid and parathyroid surgery. World Journal of Surgery 2012;36:2509-2515. doi: 10.1007/s00268-012-1674-1.